• GT Biopharma amended its bylaws effective June 8, 2026, lowering the shareholder meeting quorum threshold.
• Quorum now requires holders of at least one-third of outstanding voting shares present in person or by proxy, down from a majority.
• The change aims to reduce the risk of failed meetings as brokers increasingly avoid discretionary voting of shares held in street name.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. GT Biopharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-028457), on June 12, 2026, and is solely responsible for the information contained therein.